Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities

References

• Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010–2016. JAMA. 2018;319(17):1819–1821. doi: 10.1001/jama.2018.2844.
   PubMed Web of Science ®Google Scholar
• Green TC, Gilbert M. Counterfeit medications and fentanyl. JAMA Intern Med. 2016;176(10):1555–1557. doi: 10.1001/jamainternmed.2016.4310.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. https:www.dea.gov [Internet]. Springfield (VA): United States Drug Enforcement Administration; [cited 2023 Apr 18]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-health-care-professionals-risks-patients-exposed-xylazine-illicit-drugs
   Google Scholar
• Kariisa M, O'Donnell J, Kumar S, et al. Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine—United States, January 2019–June 2022. MMWR Morb Mortal Wkly Rep. 2023;72(26):721–727. doi: 10.15585/mmwr.mm7226a4.
   PubMed Web of Science ®Google Scholar
• Friedman J, Montero F, Bourgoi P, et al. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;233:109380. doi: 10.1016/j.drugalcdep.2022.109380.
   PubMed Web of Science ®Google Scholar
• Chhabra N, Mir M, Hua MJ, et al. Notes from the field: xylazine related deaths – Cook County, Illinois, 2017–2021. MMWR Morb Mortal Wkly Rep. 2022;71(13):503–504. doi: 10.15585/mmwr.mm7113a3.
   PubMed Web of Science ®Google Scholar
• Kariisa M, Patel P, Smith H, et al. Xylazine detection and involvement in drug overdose deaths – United States 2019. MMWR Morb Mortal Wkly Rep. 2021;70(37):1300–1302. doi: 10.15585/mmwr.mm7037a4.
   PubMed Web of Science ®Google Scholar
• Johnson J, Pizzicato L, Johnson C, et al. Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania 2010–2019. Inj Prev. 2021;27(4):395–398. doi: 10.1136/injuryprev-2020-043968.
   PubMed Web of Science ®Google Scholar
• Thangada S, Clinton HA, Ali S, et al. Xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths—Connecticut, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1303–1304. doi: 10.15585/mmwr.mm7037a5.
   PubMed Web of Science ®Google Scholar
• Sibbesen J, Abate MA, Dai Z, et al. Characteristics of xylazine-related deaths in West Virginia—xylazine-related deaths. Am J Addict. 2023;32(3):309–313. doi: 10.1111/ajad.13365.
   PubMed Web of Science ®Google Scholar
• Choi S, Irwin MR, Kiyatkin EA. Xylazine effects on opioid-induced brain hypoxia. Psychopharmacology. 2023;240(7):1561–1571. doi: 10.1007/s00213-023-06390-y.
   PubMed Web of Science ®Google Scholar
• Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, et al. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature. Forensic Sci Int. 2014;240:1–8. doi: 10.1016/j.forsciint.2014.03.015.
   PubMed Web of Science ®Google Scholar
• Nunez J, DeJoseph M, Gill JR. Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths. Am J Forensic Med Pathol. 2021;42(1):9–11. doi: 10.1097/PAF.0000000000000622.
   PubMed Web of Science ®Google Scholar
• Love JS, Levine M, Aldy K, et al. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol. 2023;61(3):173–180. doi: 10.1080/15563650.2022.2159427.
   PubMed Web of Science ®Google Scholar
• Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984;230(1):232–236.
   PubMed Web of Science ®Google Scholar
• Fyffe JJ. Effects of xylazine on humans: a review. Aust Vet J. 1994;71(9):294–295. doi: 10.1111/j.1751-0813.1994.tb03448.x.
   PubMed Web of Science ®Google Scholar
• Carruthers SG, Nelson M, Wexler HR, et al. Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol. 1979;15(3):281–285. doi: 10.3109/15563657908989878.
   PubMed Web of Science ®Google Scholar
• Poklis A, Mackell MA, Case M. Xylazine in human tissues and fluids in a case of fatal drug abuse. J Anal Toxicol. 1985;9(5):234–236. doi: 10.1093/jat/9.5.234.
   PubMed Web of Science ®Google Scholar
• Lewis S, O'Callaghan CL, Toghill PJ. Clinical curio: self medication with xylazine. Br Med J (Clin Res Ed). 1983;287(6402):1369. doi: 10.1136/bmj.287.6402.1369.
   PubMedGoogle Scholar
• Elejalde JI, Louis CJ, Elcuaz R, et al. Drug abuse with inhalated xylazine. Eur J Emerg Med. 2003;10(3):252–253. doi: 10.1097/00063110-200309000-00022.
   PubMed Web of Science ®Google Scholar
• Spoerke DG, Hall AH, Grimes MJ, et al. Human overdose with the veterinary tranquilizer xylazine. Am J Emerg Med. 1986;4(3):222–224. doi: 10.1016/0735-6757(86)90070-7.
   PubMed Web of Science ®Google Scholar
• Ball NS, Knable BM, Relich TA, et al. Xylazine poisoning: a systematic review. Clin Toxicol. 2022;60(8):892–901. doi: 10.1080/15563650.2022.2063135.
   PubMed Web of Science ®Google Scholar
• Samanta A, Roffe C, Woods KL. Accidental self administration of xylazine in a veterinary nurse. Postgrad Med J. 1990;66(773):244–245. doi: 10.1136/pgmj.66.773.244.
   PubMed Web of Science ®Google Scholar
• Romero TRL, Pacheco DDF, Duarte IDG. Xylazine induced central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ- or κ-opioid receptors. Brain Res. 2013;1506:58–63. doi: 10.1016/j.brainres.2013.02.030.
   PubMed Web of Science ®Google Scholar
• Ware TD, Paul D. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments. Eur J Pharmacol. 2000;389(2–3):181–185. doi: 10.1016/s0014-2999(99)00900-0.
   PubMed Web of Science ®Google Scholar
• Root-Bernstein R, Churchhill B. Co-evolution of opioid and adrenergic ligands and receptors: shared, complementary modules explain evolution of functional. Life. 2021;11(11):1217. doi: 10.3390/life11111217.
   PubMedGoogle Scholar
• Russell E, Sisco E, Thomson A, et al. Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction response – eight syringe services programs, Maryland, November 2021–August 2022. MMWR Morb Mortal Wkly Rep. 2023;72(17):458–462. doi: 10.15585/mmwr.mm7217a2.
   PubMedGoogle Scholar
• Nakamura M, Ferreira SH. Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances. Eur J Pharmacol. 1988;146(2–3):223–228. doi: 10.1016/0014-2999(88)90296-8.
   PubMed Web of Science ®Google Scholar
• Holt AC, Schwope DM, Le K, et al. Widespread distribution of xylazine detected throughout the United States in healthcare patient samples. J Addict Med. 2023;17(4):468–470. doi: 10.1097/ADM.0000000000001132.
   PubMed Web of Science ®Google Scholar
• Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clin Toxicol. 2014;52(5):454–469. doi: 10.3109/15563650.2014.898770.
   Web of Science ®Google Scholar
• Karppanen H, Paakkari I, Paakkari P. Further evidence for central histamine H2-receptor involvement in the hypotensive effect of clonidine in the rat. Eur J Pharmacol. 1977;42(3):299–302. doi: 10.1016/0014-2999(77)90297-7.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Meister CM, Golle K, et al. Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol. 2001;25(4):245–249. doi: 10.1093/jat/25.4.245.
   PubMed Web of Science ®Google Scholar
• Romero TR, de Castro Perez A, de Francischi JN, et al. Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine. Eur J Pharmacol. 2009;608(1–3):23–27. doi: 10.1016/j.ejphar.2009.02.019.
   PubMed Web of Science ®Google Scholar
• Toce MS, Freiman E, O'Donnell KA, et al. Clinical effects of pediatric clonidine exposure: a retrospective cohort study at a single tertiary care center. J Emerg Med. 2021;60(1):58–66. doi: 10.1016/j.jemermed.2020.09.018.
   PubMed Web of Science ®Google Scholar
• Kunos G, Farsang C, Ramirez-Gonzales MD. beta-Endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation. Science. 1981;211(4477):82–84. doi: 10.1126/science.6108611.
   PubMed Web of Science ®Google Scholar
• Farsang C, Vajda L, Kapocsi J, et al. Diurnal rhythm of beta endorphin in normotensive and hypertensive patients: the effect of clonidine. J Clin Endocrinol Metab. 1983;56(4):865–867. doi: 10.1210/jcem-56-4-865.
   PubMed Web of Science ®Google Scholar
• Seger DL, Loden KJ. Naloxone reversal of clonidine toxicity: dose, dose, dose. Clin Toxicol. 2018;56(10):873–879. doi: 10.1080/15563650.2018.1450986.
   PubMed Web of Science ®Google Scholar
• Smith MA, Biancorosso SL, Camp JD, et al. "Tranq-dope" overdose and mortality: lethality induced by fentanyl and xylazine. Front Pharmacol. 2023;14:1280289. doi: 10.3389/fphar.2023.1280289.
   PubMed Web of Science ®Google Scholar
• Gallanosa A, Spyker DA, Shipe JR, et al. Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants. Clin Toxicol. 1981;18(6):663–678. doi: 10.3109/15563658108990293.
   PubMed Web of Science ®Google Scholar
• Capraro AJ, Wiley JF, Tucker JR. Severe intoxication from xylazine inhalation. Pediatr Emerg Care. 2001;17(6):447–448. doi: 10.1097/00006565-200112000-00012.
   PubMed Web of Science ®Google Scholar
• Wong SC, Curtis JA, Wingert WE. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia medical examiner’s office. J Forensic Sci. 2008;53(2):495–498. doi: 10.1111/j.1556-4029.2007.00648.
   PubMed Web of Science ®Google Scholar
• Torruella RA. Xylazine (veterinary sedative) use in Puerto Rico. Subst Abuse Treat Prev Policy. 2011;6(1):7. doi: 10.1186/1747-597X-6-7.
   PubMedGoogle Scholar
• Spadaro A, O'Connor K, Lakamana S, et al. Self-reported xylazine experiences: a mixed methods study of Reddit subscribers. J Addict Med. 2023;17(6):691–694. doi: 10.1097/ADM.0000000000001216.
   PubMedGoogle Scholar
• Reed MK, Imperato NS, Bowles JM, et al. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; making a case for xylazine test strips. Drug Alcohol Depend Rep. 2022;4:100074. doi: 10.1016/j.dadr.2022.100074.
   PubMedGoogle Scholar
• Reyes JC, Negrón JL, Colón HM, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health. 2012;89(3):519–526. doi: 10.1007/s11524-011-9662-6.
   PubMed Web of Science ®Google Scholar
• Velez LI, Shepherd G, Mills LD, et al. Systemic toxicity after an ocular exposure to xylazine hydrochloride. J Emerg Med. 2006;30(4):407–410. doi: 10.1016/j.jemermed.2006.02.042.
   PubMed Web of Science ®Google Scholar